SamSearch

    Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES

    Assay Development for Superior Understanding of Response and Efficacy (ASSURE)

    Issued by OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE · ASPR BARDA DIV CONTRACTS MGMT & ACQ
    Sol. RRPV-26-07-ASSURESolicitationSet-aside: No Set aside usedWashington, DC
    Closed
    STATUS
    Closed
    closed Dec 18, 2025
    POSTED
    Nov 17, 2025
    Publication date
    NAICS CODE
    541714
    Primary industry classification
    PSC CODE
    AN42
    Product & service classification

    AI Summary

    The ASSURE program seeks to develop innovative assays for evaluating immune responses to infections and vaccinations. This solicitation aims to establish new assay technologies for BARDA and vaccine developers, focusing on comprehensive immune status assessment related to CBRN threats and emerging infectious diseases.

    Contract details

    Solicitation No.
    RRPV-26-07-ASSURE
    Notice Type
    Solicitation
    Set-Aside
    No Set aside used
    Posted Date
    November 17, 2025
    Response Deadline
    December 18, 2025
    NAICS Code
    541714AI guide
    PSC / Class Code
    AN42
    Contract Code
    7505
    Issuing Office
    ASPR BARDA DIV CONTRACTS MGMT & ACQ
    Sub-Agency
    OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
    Agency
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Primary Contact
    Rebecca Harmon
    City
    Washington
    State
    DC
    ZIP Code
    20515
    AI Product/Service
    service

    Description

    The ASSURE program aims to develop innovative, multiplexed, high-throughput, scalable and sample sparing assays that provide comprehensive evaluation of an individual’s immune status as a response to either infection or vaccination. This program seeks to de-risk the development of novel assay platform technologies with the ultimate goal of establishing new, qualified assays primarily for BARDA and vaccine developers to comprehensively assess the immune response and status elicited by vaccines and/or infection due to CBRN threats, pandemic influenza, or other emerging infectious diseases. Some of these assays may lead to support of new correlates of protection.

    Key dates

    1. November 17, 2025Posted Date
    2. December 18, 2025Proposals / Responses Due

    AI search tags

    assay developmentimmune responsevaccine developmentbiomedical researchinfectious diseases

    Frequently asked questions

    Assay Development for Superior Understanding of Response and Efficacy (ASSURE) is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.

    Book a Demo